Drug-induced secondary agranulocytosis (Q92212): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:21, 16 August 2026
This refers to a drug-induced secondary, acute condition involving a severe and dangerous leukopenia (lowered white blood cell count), most commonly of neutrophils causing a neutropaenia in the circulating blood.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1897183140 |
||
| English | Drug-induced secondary agranulocytosis |
This refers to a drug-induced secondary, acute condition involving a severe and dangerous leukopenia (lowered white blood cell count), most commonly of neutrophils causing a neutropaenia in the circulating blood. |
Statements
CID11:ID_1897183140
0 references
dki-india-ID_1897183140
0 references
Concluído
0 references
15 August 2026
0 references
